UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
__________________________
FORM 6-K
__________________________
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT
TO
RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of September 2014
Commission File Number: 001-35152
__________________________
WI-LAN INC.
(Translation of registrant’s name
into English)
__________________________
303 Terry Fox Drive
Suite 300
Ottawa, Ontario K2K 3J1
Canada
(Address of principal executive office)
__________________________
Indicate by check mark whether the registrant files or will
file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ¨ Form 40-F þ
Indicate by check mark if the registrant is submitting the Form
6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ¨
Indicate by check mark if the registrant is submitting the Form
6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ¨
EXHIBIT LIST
Exhibit |
|
Description |
|
|
|
99.1 |
|
Press Release dated September 29, 2014
|
99.2 |
|
Press Release dated September 29, 2014 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act
of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
WI-LAN INC. |
|
|
|
|
|
|
|
Date: September 29, 2014 |
By: |
/s/ Prashant R. Watchmaker |
|
|
Name: Prashant R. Watchmaker |
|
|
|
Title: Vice-President, Corporate Legal & Corporate Secretary |
Exhibit 99.1
|
Press
release
|
WiLAN Subsidiary Enters License Agreement
with Stryker
Stryker license
represents WiLAN’s first in medical field
OTTAWA, Canada
– September 29, 2014 – Top intellectual property licensing company, WiLAN (TSX:WIN) (NASD:WILN), today announced
that a wholly-owned subsidiary of the company has granted Stryker Corporation (“Stryker”) a license to certain patents
related to medical stent technology. WiLAN secured the rights to license the patents through an agreement executed in June 2014.
“We are pleased
that Stryker has signed this license,” said Jim Skippen, President & CEO. “This license agreement demonstrates
our ability to develop and execute licensing programs in new markets such as medical technologies. It also demonstrates our ability
to generate timely results for our partners.”
The consideration
to be paid by Stryker to WiLAN and all other terms of the license agreement are confidential.
About WiLAN
WiLAN, founded in
1992, is a leading technology innovation and licensing company. WiLAN has licensed its intellectual property to over 285 companies
worldwide. Inventions in our portfolio have been licensed by companies that manufacture or sell a wide range of communication
and consumer electronics products including 3G and 4G handsets, Wi-Fi-enabled laptops, Wi-Fi and broadband routers, xDSL infrastructure
equipment, cellular base stations and digital TV receivers. For more information: www.wilan.com.
Forward-looking Information
This news release contains forward-looking
statements and forward-looking information within the meaning of the U.S. Private Securities Litigation Reform Act of 1995 and
other United States and Canadian securities laws. The phrases “to develop and execute”, “to generate”,
“to be paid” and similar terms and phrases are intended to identify these forward-looking statements. Forward-looking
statements and forward-looking information are based on estimates and assumptions made by WiLAN in light of its experience and
its perception of historical trends, current conditions, expected future developments and the expected effects of new business
strategies, as well as other factors that WiLAN believes are appropriate in the circumstances. Many factors could cause WiLAN's
actual performance or achievements to differ materially from those expressed or implied by the forward-looking statements or forward-looking
information. Such factors include, without limitation, the risks described in WiLAN’s February 3, 2014 annual information
form for the year ended December 31, 2013 (the “AIF”). Copies of the AIF may be obtained at www.sedar.com or
www.sec.gov. WiLAN recommends that readers review and consider all of these risk factors and notes that readers should
not place undue reliance on any of WiLAN's forward-looking statements. WiLAN has no intention and undertakes no obligation to
update or revise any forward-looking statements or forward-looking information, whether as a result of new information, future
events or otherwise, except as required by law.
All trademarks
and brands mentioned in this release are the property of their respective owners.
- ## -
www.wilan.com |
© copyright Wi-LAN 2014 |
1 |
|
Press
release
|
For media and investor inquiries, please
contact:
Tyler Burns
Director, Investor Relations
O: 613.688.4330
C: 613.697.0367
E: tburns@wilan.com |
www.wilan.com |
© copyright Wi-LAN 2014 |
2 |
Exhibit 99.2
|
Press
release
|
WiLAN Subsidiary Enters License Agreement
with Asurion
OTTAWA, Canada
– September 29, 2014 – Top intellectual property licensing company, WiLAN (TSX:WIN) (NASD:WILN), today announced
that a wholly-owned subsidiary of the company has granted Asurion LLC (“Asurion”) a license to certain patents related
to data device security. WiLAN secured the rights to license the patents through a licensing partnership agreement executed in
August 2013.
The consideration
to be paid by Asurion to the WiLAN and all other terms of the license agreement are confidential. All litigation between the parties
will be dismissed.
About WiLAN
WiLAN, founded in
1992, is a leading technology innovation and licensing company. WiLAN has licensed its intellectual property to over 285 companies
worldwide. Inventions in our portfolio have been licensed by companies that manufacture or sell a wide range of communication
and consumer electronics products including 3G and 4G handsets, Wi-Fi-enabled laptops, Wi-Fi and broadband routers, xDSL infrastructure
equipment, cellular base stations and digital TV receivers. For more information: www.wilan.com.
Forward-looking Information
This news release contains forward-looking statements and forward-looking
information within the meaning of the U.S. Private Securities Litigation Reform Act of 1995 and other United States and Canadian
securities laws. The phrases “to be paid”, “will be dismissed” and similar terms and phrases are
intended to identify these forward-looking statements. Forward-looking statements and forward-looking information are based on
estimates and assumptions made by WiLAN in light of its experience and its perception of historical trends, current conditions,
expected future developments and the expected effects of new business strategies, as well as other factors that WiLAN believes
are appropriate in the circumstances. Many factors could cause WiLAN's actual performance or achievements to differ materially
from those expressed or implied by the forward-looking statements or forward-looking information. Such factors include, without
limitation, the risks described in WiLAN’s February 3, 2014 annual information form for the year ended December 31, 2013
(the “AIF”). Copies of the AIF may be obtained at www.sedar.com or www.sec.gov. WiLAN recommends that
readers review and consider all of these risk factors and notes that readers should not place undue reliance on any of WiLAN's
forward-looking statements. WiLAN has no intention and undertakes no obligation to update or revise any forward-looking statements
or forward-looking information, whether as a result of new information, future events or otherwise, except as required by law.
All trademarks and brands mentioned in this
release are the property of their respective owners.
- ## -
www.wilan.com |
© copyright Wi-LAN 2014 |
1 |
|
Press
release
|
For media and investor inquiries, please
contact:
Tyler Burns
Director, Investor Relations
O: 613.688.4330
C: 613.697.0367
E: tburns@wilan.com |
www.wilan.com |
© copyright Wi-LAN 2014 |
2 |
Quarterhill (NASDAQ:QTRH)
Historical Stock Chart
From Mar 2024 to Apr 2024
Quarterhill (NASDAQ:QTRH)
Historical Stock Chart
From Apr 2023 to Apr 2024